AcquisitionMOR expects the acquisition by Novartis to close, which could streamline regulatory processes and benefit the company's strategic positioning.
Product PipelineThe company plans to submit filings for regulatory approvals for pelabresib, showing progress in its product pipeline.
Regulatory ApprovalAntitrust clearance from Germany and Austria has been received, and filings in the US are underway, indicating regulatory hurdles are being addressed.